Moderators: Dr Johannes Löwer, Germany, and Dr Ashwini Kumar, India
Blood products are classified as biologicals, and their efficacy and safety is affected by their complex nature and the process used to manufacture them. Blood products can be divided into two groups:
• blood and blood components derived from single donations or small pools, and
• plasma-derived products obtained from fractionation of plasma pools comprising several thousand plasma units.